Page 2 - Affairs Regulatory News Today : Breaking News, Live Updates & Top Stories | Vimarsana

AstraZeneca India to set up 5 centres of excellence to boost asthma care

UK drugmaker AstraZeneca's India arm on Tuesday announced plans to launch five centres of excellence across the country to provide a systematic approach to standardised and uniform management of patients with severe asthma.The centres, to be .

New delhiUnited kingdomGlobal initiative for asthmaCenters of excellence coesAffairs regulatoryWorld asthmaGlobal initiativeAnil kukrejaVice presidentAstrazeneca india

AstraZeneca India to set up 5 centres of excellence to boost asthma care

AstraZeneca India to set up 5 centres of excellence to boost asthma care
webindia123.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from webindia123.com Daily Mail and Mail on Sunday newspapers.

United kingdomAffairs regulatoryCenters of excellence coesGlobal initiative for asthmaWorld asthmaGlobal initiativeAnil kukrejaVice presidentAstrazeneca india

What s Ahead In Pharma - BW Businessworld

India, known as the pharmacy of the world, is the 3rd biggest producer of medicines by volume and 14th by value. With a fleet of 3,000 domestic drug companies and 10,500 manufacturing units, the country enjoys a crucial place in the global pharmaceutical sector, , indian pharmaceutical industry, pharmaceutical, astrazeneca pharma india, Akums Drugs & Pharmaceuticals Ltd, nirmala sitharaman, healthcare

United kingdomSajjan singhNirmala sitharamanAarushi jainGaurav shuklaMansukh mandaviyaIndian economicAuthentication solution provider associationAffairs regulatoryDrug administrationPowerhouse of researchA catalyst networkWorld health organisationAkums drugs pharmaceuticals ltdPharmaceuticals export promotion council of india pharmexcilData security council of india

AstraZeneca India s NSCLC drug Tagrisso receives marketing approval

AstraZeneca India s NSCLC drug Tagrisso receives marketing approval
biospectrumindia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biospectrumindia.com Daily Mail and Mail on Sunday newspapers.

Gagandeep singh bediAstrazeneca pharma indiaAffairs regulatoryAstrazeneca pharma india limitedSingh bediManaging directorAstrazeneca indiaNon small cell lung cancerAnil kukrejaVice presidentMedical affairsககந்டீப் சிங் பேடிவாழ்க்கைத்தொழில்கள் ஒழுங்குமுறைசிங் பேடிநிர்வகித்தல் இயக்குனர்அல்லாத சிறிய செல் நுரையீரல் புற்றுநோய்

AstraZeneca India s anti-diabetic drug dapagliflozin cleared for CKD treatment

AstraZeneca India s anti-diabetic drug receives approval for CKD treatment AstraZeneca India s anti-diabetic drug receives approval for CKD treatment 08 February 2021 | News AstraZeneca’s dapagliflozin is the first medicine in SGLT-2i class to move into a new disease area by demonstrating efficacy and safety data for the treatment of patients with chronic kidney disease (CKD) Source credit: Shutterstock AstraZeneca India (AstraZeneca Pharma India Limited), a leading science-led biopharmaceutical company, announced that they have received marketing authorisation for their anti-diabetic drug dapagliflozin, in India for the treatment of patients of chronic kidney disease (CKD) up to Stage III. The receipt of this permission paves way for the launch of Dapagliflozin Tablets 10mg into a new disease area to nephrologists in India.

Dinesh khullarNational lead investigatorAstrazeneca india pharmaAffairs regulatoryAstrazeneca indiaAstrazeneca pharma india limitedDapagliflozin tabletsAnil kukrejaVice presidentMedical affairsDits approvalAnti diabetic drugDapa ckd studySglt 2i classதினேஷ் குள்ளார்தேசிய வழி நடத்து புலனாய்வாளர்